The Prognostic Nutrition Index Predicts the Development of Hematological Toxicities in and the Prognosis of Esophageal Cancer Patients Treated with Cisplatin Plus 5-Fluorouracil Chemotherapy

References

• Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, et al.: The global burden of cancer 2013. JAMA Oncol 1(4), 505–27, 2015. doi:10.1001/jamaoncol.2015.0735.
   PubMed Web of Science ®Google Scholar
• Sohda M and Kuwano H: Current status and future prospects for esophageal cancer treatment. Ann Thorac Cardiovasc Surg 23(1), 1–11, 2017. doi:10.5761/atcs.ra.16-00162.
   PubMed Web of Science ®Google Scholar
• Filip B, Scarpa M, Cavallin F, Cagol M, Alfieri R, et al.: Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol 41(6), 787–794, 2015. doi:10.1016/j.ejso.2015.02.014.
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, and Kosaki G: Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85(9), 1001–1005, 1984.
   PubMedGoogle Scholar
• Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, et al.: Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol 28(4), 396–400, 2002. doi:10.1053/ejso.2002.1257.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao P, Song Y, Sun J, Chen X, et al.: The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol 42(8), 1176–1182, 2016. doi:10.1016/j.ejso.2016.05.029.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Tamura T, Toyokawa T, Amano R, Kubo N, et al.: Low preoperative prognostic nutritional index predicts poor survival post-gastrectomy in elderly patients with gastric cancer. Ann Surg Oncol 23(11), 3669–3676, 2016. doi:10.1245/s10434-016-5272-6.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wei Y, Huang F, Wei X, Wei Q, et al.: Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP. Int J Hematol 104(4), 485–490, 2016. doi:10.1007/s12185-016-2052-9.
   PubMed Web of Science ®Google Scholar
• Sheng J, Yang YP, Ma YX, Qin T, Hu ZH, et al.: Low prognostic nutritional index correlates with worse survival in patients with advanced NSCLC following EGFR-TKIs. PLoS One 11(1), e0147226, 2016. doi:10.1371/journal.pone.0147226.
   PubMed Web of Science ®Google Scholar
• Wu J, Huang C, Xiao H, Tang Q, and Cai W: Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition 29(11–12), 1310–1314, 2013. doi:10.1016/j.nut.2013.04.010.
   PubMed Web of Science ®Google Scholar
• Chen S, Yang X, and Feng JF: A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the C-reactive protein/prognostic nutritional index ratio. Oncotarget 7(38), 62123–62132, 2016. doi:10.18632/oncotarget.11389.
   PubMedGoogle Scholar
• Feng JF and Chen QX: Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma. Ther Clin Risk Manag 10, 1–7, 2014.
   PubMed Web of Science ®Google Scholar
• Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, et al.: The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 20(8), 2647–2654, 2013. doi:10.1245/s10434-013-2926-5.
   PubMed Web of Science ®Google Scholar
• Grünberger B, Raderer M, Schmidinger M, and Hejna M: Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res 27(4C), 2705–2714, 2007.
   PubMed Web of Science ®Google Scholar
• Sun J, Wang D, Mei Y, Jin H, Zhu K, et al.: Value of the prognostic nutritional index in advanced gastric cancer treated with preoperative chemotherapy. J Surg Res 209, 37–44, 2017. doi:10.1016/j.jss.2016.09.050.
   PubMed Web of Science ®Google Scholar
• Seo SH, Kim SE, Kang YK, Ryoo BY, Ryu MH, et al.: Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients. BMC Cancer 16(1), 900, 2016. doi:10.1186/s12885-016-2934-5.
   PubMed Web of Science ®Google Scholar
• Alexandre J, Gross-Goupil M, Falissard B, Nguyen ML, Gornet JM, et al.: Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol 14, 36–41, 2003. doi:10.1093/annonc/mdg013.
   PubMed Web of Science ®Google Scholar
• Kamimura K, Matsumoto Y, Zhou Q, Moriyama M, and Saijo Y: Myelosuppression by chemotherapy in obese patients with gynecological cancers. Cancer Chemother Pharmacol 78(3), 633–641, 2016. doi:10.1007/s00280-016-3119-2.
   PubMed Web of Science ®Google Scholar
• Gullo JJ, Litterst CL, Maguire PJ, Sikic BI, Hoth DF, et al.: Pharmacokinetics and protein binding of cis-dichlorodiamine platinum (II) administered as a one hour or as a twenty hour infusion. Cancer Chemother Pharmacol 5(1), 21–26, 1980. doi:10.1007/BF00578558.
   PubMed Web of Science ®Google Scholar
• Gabay C and Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6), 448–454, 1999. doi:10.1056/NEJM199902113400607.
   PubMed Web of Science ®Google Scholar
• Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, et al.: Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16(9), 1090–1098, 2015. doi:10.1016/S1470-2045(15)00040-6.
   PubMed Web of Science ®Google Scholar
• Honing J, Smit JK, Muijs CT, Burgerhof JG, de Groot JW, et al.: A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients. Ann Oncol 25(3), 638–643, 2014. doi:10.1093/annonc/mdt589.
   PubMed Web of Science ®Google Scholar